The Viral Immunity and Immunopathology Laboratory at
@Hudson_Research
@CiiiD_Research
Host-directed therapies for #influenza and pulmonary inflammation
🫁 It’s the epithelium, not myeloid cells.
Epithelial NLRP3 drives lung injury and fibrosis via IL‑18 and pro‑fibrotic neutrophils.
https://t.co/5wtqMQp31V
Although there are no effective drugs for severe influenza, a breakthrough led by @Tate_Lab in collaboration with Associate Professor Ashley Mansell, led to innovative treatments that target the body rather than the virus itself to limit inflammation and save lives.
Read more in NHMRC’s 10 of the Best 17th Edition now on our website: https://t.co/dN7YF4wqtX
Exciting news! The AVS12 Meeting Report is now published in the @ASMicrobiology Journal of Virology 🎉
AVS prides itself on supporting all voices in virology through career development, Indigenous engagement, collaboration, and recognition of excellence.
https://t.co/UchixsSuOB
🚨 Registrations for #AVS12 are still open! 🚨
📅 Dec 2-5 | 📍 RACV Goldfields, Creswick, VIC
Join us for an unforgettable event!
🔗 Register now: https://t.co/hSsH3VhE1X
When patients with severe flu are admitted to hospital there are no effective drugs available to reduce the response to the virus. Our researchers are focusing on finding treatments to help these patients
2024 flu season guide: https://t.co/yvOEoNEv5e
@Tate_Lab @CiiiD_Research
Lung Foundation Australia's Hope Research Fund grants for 2024 have been awarded! We would like to offer our congratulations to the early and mid-career PHDs and fellowships awardees 👏
A/Prof Michelle Tate, PhD student Sarah Rosli & their team have identified a protein, Gasdermin D, in lung epithelial cells which promotes hyper-inflammation & cell death in severe cases of #Influenza. 🫁 Read more: https://t.co/Lec4Ae7xT1